There are currently 374 clinical trials in Stanford, California looking for participants to engage in research studies. Trials are conducted at various facilities, including Stanford University, Stanford University School of Medicine, Stanford University Medical Center and Stanford Cancer Center. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation
NCT01656603
Recruiting
This study will evaluate the safety of infusion of the investigational cord blood units by carefully documenting all infusion-related problems.
Gender:
ALL
Ages:
All
Trial Updated:
04/17/2024
Locations: Stanford Health Care, Stanford, California
Conditions: Infusion Reactions
Register for Updates
Clinical Trial of Endoscopically Guided Injection of Exparel (Bupivacaine) for the Treatment of Craniofacial Pain
NCT04930887
Recruiting
Exparel has a proven efficacy in providing pain relief for up to 72 hours with a single-dose administration at surgical sites. The study aims to evaluate the effectiveness of endoscopically-guided injection of Exparel (Bupivacaine) for the treatment of craniofacial pain. This study would be conducted in a prospective, randomized, double-blinded, placebo- controlled, and cross-over fashion. We aim to investigate whether the administration of Exparel (Bupivacaine) to the lateral nasal wall may pos... Read More
Gender:
ALL
Ages:
Between 18 years and 80 years
Trial Updated:
04/16/2024
Locations: Peter H Hwang, Stanford, California
Conditions: Craniofacial Pain, Migraine, Cluster Headache, Trigeminal Autonomic Cephalgia, Sphenopalatine Ganglion Neuralgia, Paroxysmal Hemicrania
Register for Updates
Open-label Extension Study of GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH)
NCT04816604
Recruiting
This open-label extension study will evaluate the long-term effects of GB002 (seralutinib) in subjects who previously participated in a GB002 PAH study.
Gender:
ALL
Ages:
Between 18 years and 80 years
Trial Updated:
04/16/2024
Locations: Stanford Health Care, Stanford, California
Conditions: Pulmonary Arterial Hypertension
Register for Updates
Effects of Movement Retraining on Knee Loading in Individuals With Knee Osteoarthritis
NCT06208631
Recruiting
This study investigates how well individuals with knee osteoarthritis can learn to alter their calf muscle activation using haptic biofeedback while walking and evaluates how these changes affect knee loading. Prior research has utilized musculoskeletal simulations to determine that reducing the activation of one of the calf muscles, the gastrocnemius, can have a large impact on reducing knee loading. However, this has not been tested in individuals with knee osteoarthritis. In this study, part... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
04/16/2024
Locations: Stanford Human Performance Lab, Stanford, California
Conditions: Osteoarthritis, Knee
Register for Updates
Personalized Escalation of Consolidation Treatment Following Chemoradiotherapy and Immunotherapy in Stage III NSCLC in Stage III NSCLC
NCT04585490
Recruiting
The purpose of this study is to test whether or not number of circulating cancer cells detected in the blood can be decreased the by combining the standard treatment (durvalumab) with Tremelimumab and additional chemotherapy
Gender:
ALL
Ages:
18 years and above
Trial Updated:
04/15/2024
Locations: Stanford University, Stanford, California
Conditions: Non Small Cell Lung Cancer, NSCLC, Stage III, Nsclc
Register for Updates
99mTc Sestamibi SPECT/CT vs 18F Fluorocholine PET/CT
NCT05891769
Recruiting
This study proposes the use of a well-established PET isotope, Fluorine-18 (18F), bound to Choline, for a prospective single-center, single-arm study for participants with suspected parathyroid adenoma and negative or equivocal standard of care 99mTc Sestamibi SPECT/CT
Gender:
ALL
Ages:
18 years and above
Trial Updated:
04/15/2024
Locations: Stanford Hospital and Clinics, Stanford, California
Conditions: Parathyroid Adenoma
Register for Updates
BEAD-T1D: Building the Evidence to Address Disparities in Type 1 Diabetes
NCT05488119
Recruiting
Youth from low socioeconomic groups are at a systematic disadvantage in the provision of diabetes care, particularly diabetes technology which is associated with improvement in diabetes-specific outcomes. Thus, the type 1 diabetes community urgently need studies to understand and ameliorate the persistent worsening of disparities of diabetes management and outcomes in youth from low socioeconomic backgrounds. This proposed research will (1) improve representation of diverse youth in the literatu... Read More
Gender:
ALL
Ages:
12 years and above
Trial Updated:
04/15/2024
Locations: Stanford University, Stanford, California
Conditions: Type 1 Diabetes
Register for Updates
Bumetanide in Patients With Alzheimer's Disease
NCT06052163
Recruiting
This study aims to investigate bumetanide in patients with biologically confirmed Alzheimer's disease (AD). Bumetanide is a potent diuretic administered orally and is FDA approved for the treatment of edema and hypertension. Repurposing bumetanide as a medication for AD has been proposed based on data that demonstrated its ability to "flip" the APOE genotype-dependent transcriptomic signatures in AD mouse and cell culture models. Critically, this discovery was subsequently explored in Electronic... Read More
Gender:
ALL
Ages:
Between 50 years and 85 years
Trial Updated:
04/10/2024
Locations: Stanford University, Stanford, California
Conditions: Alzheimer Disease
Register for Updates
A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)
NCT05685433
Recruiting
A prospective, multicenter, single-arm study to evaluate the safety and effectiveness of the eCoin® implanted tibial nerve stimulator in subjects with urgency urinary incontinence (UUI).
Gender:
ALL
Ages:
18 years and above
Trial Updated:
04/06/2024
Locations: Stanford Health, Stanford, California
Conditions: Overactive Bladder, Urge Incontinence, Incontinence, Urinary, Urinary Urge Incontinence
Register for Updates
Comparing the Stanford Letter Project Form to Traditional Advance Directives
NCT02799537
Recruiting
Our goal is to compare two types of advance directives forms available in English and Spanish to determine which is more easy to use for patients.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
04/04/2024
Locations: Stanford School of Medicine, Stanford, California
Conditions: Advance Directives, Palliative Care
Register for Updates
64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)
NCT04868604
Recruiting
The aim of this study is to determine the safety and efficacy of 67Cu-SAR-bisPSMA in participants with PSMA-expressing metastatic castrate resistant prostate cancer.
Gender:
MALE
Ages:
18 years and above
Trial Updated:
03/26/2024
Locations: Stanford Cancer Institute, Stanford, California
Conditions: Prostatic Neoplasms, Castration-Resistant
Register for Updates
Double-S: a Wearable Device for Erectile Dysfunction
NCT05451563
Recruiting
The purpose of this study is to use a minimally invasive erectile device for patients suffering from erectile dysfunction.
Gender:
MALE
Ages:
18 years and above
Trial Updated:
03/25/2024
Locations: Stanford Healthcare, Stanford Hospital, Stanford, California
Conditions: Erectile Dysfunction
Register for Updates